Rev1 Capital
Rev1 Capital manages a continuum of more than $170 million in capital and has invested in more than 140 companies in the targeted industries of Software and Software as a Service, Life Sciences and other advanced technologies, including Manufacturing, Advanced Materials and Alternative Energy. Following is an overview of the active funds from which we are currently investing.
Future Value Fund I
Company Stage: Pre-seed and Seed-stage companies
Company Sectors: Healthcare IT, Digital Health, Human Resources technology, Fintech, Insurtech, Data Analytics, Enterprise SaaS, and Ohio State University spinouts in Advanced Materials, Alternative Energy, Sensors and Hardware, and Food and Ag Tech.
Target Geography: Central Ohio companies
Typical Investment Range: $250,000-$500,000 in up to 15 companies
Recent Investments
SureImpact, a customizable, cloud-based software platform that allows mission-driven organizations to easily manage their unique social impact.
Learn more about SureImpactRev1 Fund II
Company Stage: Seed and Early-stage companies
Company Sectors: Enterprise SaaS, Healthcare IT and Digital Health, Fintech, Data Analytics, Insurtech; select Life Sciences spinouts from The Ohio State University or Nationwide Children’s Hospital.
Target Geography: Midwest- and Great-Lakes-based companies
Typical Investment Range: $250,000-$1,000,000 in up to 15 companies
Recent Investments
Redi.health believes every patient has the ability to overcome today’s healthcare barriers if they are given the right tools. We empower patient
Learn more about Redi.Health
Upshift is a digital staffing platform that connects businesses in need of extra help with a pool of pre-vetted W-2 Workers.
Learn more about UpshiftCatalyst Fund III
Company Stage: Pre-seed, Seed and Early-stage companies
Company Sectors: Gene and Cell Therapies, Neuroscience, Biofilms, Ocular Health, Cardiovascular Health and other therapeutic technologies aligned with The Ohio State University or Nationwide Children’s Hospital
Target Geography: U.S.-based companies, with primary focus on Ohio
Typical Investment Range: $500,000-$1,000,000 in up to 12 companies
Recent Investments
Armatus Bio, based in Columbus Ohio, is an emerging biotechnology company.
Learn more about Armatus Bio
Developing a therapy and vaccine to treat and prevent pneumonia.
Learn more about Clarametyx BiosciencesLearn more about Rev1 Capital
